Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. - Wikidata - awgldk - TriplyDB

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

http://www.wikidata.org/entity/Q51762261

about

Amyloid-associated depression: a prodromal depression of Alzheimer disease?Biological markers of amyloid beta-related mechanisms in Alzheimer's disease A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's disease Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Cerebrospinal fluid and blood biomarkers in Alzheimer's disease Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.Biomarkers for cognitive impairment and dementia in elderly people.Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND).Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African Americans Multimodal techniques for diagnosis and prognosis of Alzheimer's disease Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome.Circulating biomarkers that predict incident dementia.Blood-based biomarkers of Alzheimer's disease: challenging but feasible Targeting Abeta and tau in Alzheimer's disease, an early interim report Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions.Plasma ß-amyloid and cognitive decline.Biomarkers of Alzheimer's disease: from central nervous system to periphery?Amyloid β levels in human red blood cells Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta.A serum protein-based algorithm for the detection of Alzheimer disease Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a Project FRONTIER study.Circulating miRNA biomarkers for Alzheimer's disease Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study.Biomarkers of the dementia.Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.Association between amylin and amyloid-β peptides in plasma in the context of apolipoprotein E4 allele.Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment.Relation between insulin, insulin-related factors, and plasma amyloid beta peptide levels at midlife in a population-based study.

P2860

Q22253023-1EF454C5-6C5F-4A1A-958D-227F44CF643D Q24622136-7A05C9A5-9789-48C9-9138-F1E3C2AC24FF Q26771808-710CC36C-5222-4EAE-A8B9-2F0594DC814D Q26774743-93AE3271-7930-45A5-8764-4F80DA1A6D13 Q27023758-B87A1320-C74B-469B-82EB-9AC63F0A754B Q27027319-6946F856-4BE7-41F1-BBED-0D5413B5CF77 Q27310276-14FC46C0-9122-45EC-8093-A2C37AF62EB4 Q28582464-B030F027-A9EF-4548-92B0-5D9C25A092C6 Q30315907-BBAB14F0-6B4A-42C9-AC91-0AD7FC4D038F Q30370745-79AA38C7-8E85-4179-B21D-07AE0DF07342 Q30473360-4436CDD9-467E-49C2-9C1B-2D0C8DA9CDEA Q30845482-27CB5C72-9C0D-42AB-8341-03D7237BA7F7 Q31159582-2FF0DC19-7B8E-4838-8271-29715504C440 Q33591314-D5C1651F-D5AF-4532-942D-49F82C6D7510 Q33603868-4AA6A1FE-496B-4D64-A766-E64A219DBE1C Q33607535-23317A6F-154E-4CF1-9D65-1D768C18FDA9 Q33609644-A1997265-C5B1-47A4-9678-75A34C47E061 Q33752058-64FBB931-F94A-42A1-80A6-3453323ACDDE Q33824444-5794FE3B-64A8-42BA-9108-AF5D68DFDB65 Q33829008-8A07BC07-14CA-493D-85DB-D6EA39EBBF5A Q34056793-F463C518-5F91-40C0-B2E2-87296DD5AC3A Q34292024-F8D1C8CF-1CE2-4DED-8621-081CD5C6FF68 Q34318022-D85E3FDA-DDB8-429A-BC8E-3161D3526F30 Q34424794-3A8BF355-89B6-482C-9EE9-E2E33DFE7139 Q34442605-DEAF5398-6E38-487E-96DB-F3267C9BC3EF Q34482602-3886162D-277A-4F59-88EA-BAC95A1110E6 Q34482760-E006866B-AE8F-46D7-87DA-CCED7011D6C0 Q34721090-0D312316-6AD6-41F6-BFB7-20C7D55B95CC Q34755504-F54C5A35-A226-41E7-8A6B-C98B8CF7F232 Q34786869-4611ADA0-15C1-46E1-ADC7-CAD202AB6767 Q34874674-D36CF018-91E6-45C2-8EE1-19D0E2F9B625 Q34904013-B3B03516-AC6F-470C-AEC2-84B04AC3EAA0 Q35024621-D3948AB2-531C-4810-A837-A27BDD439CF8 Q35029099-977DE8EF-3849-4263-9610-F33404C937B2 Q35030049-649F61AA-C881-489F-B19F-B1E0CF591BB9 Q35030392-05C04BCC-B46E-45C3-8103-9795137F49F2 Q35085348-BA4ADCA7-0F33-466C-9E60-2A026A519C25 Q35092684-A4704AA0-4CED-44BD-9851-80318D079DBD Q35117068-93A6FF02-9F82-400F-AB46-427EC6FDA3C1 Q35118684-BB8E5918-FF88-4F39-935E-7E07BA1AEEC2

P2860

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

http://www.wikidata.org/entity/Q51762261

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Association of low plasma Abet ...... airment and Alzheimer disease.

@en

Association of low plasma Abet ...... airment and Alzheimer disease.

@nl

type

label

Association of low plasma Abet ...... airment and Alzheimer disease.

@en

Association of low plasma Abet ...... airment and Alzheimer disease.

@nl

prefLabel

Association of low plasma Abet ...... airment and Alzheimer disease.

@en

Association of low plasma Abet ...... airment and Alzheimer disease.

@nl

P1433

Q51762261-1E4C245B-FD98-41AF-9203-DCC1E1ADA88F

P1476

Q51762261-2AE5EA6E-57A0-4D69-A582-814B2FE9B79C

P2093

Q51762261-1F10DC63-B35F-4820-B73C-58D451174D1F

Q51762261-574D89A2-D4F3-4232-9CED-7AAC332D45F3

Q51762261-6361E52F-8640-437D-8381-1A04FF2878EA

Q51762261-69F74CC3-DDB4-4119-869E-44DCD8DF61B2

Q51762261-B20F1F32-C3C4-4B78-97A1-6EE4D0306379

Q51762261-DA0A7027-D979-46F9-A455-2FA260367C59

Q51762261-DECBB62D-6CB9-488D-B94C-1B1E50C32374

Q51762261-F6AD25A2-FA0F-405B-8A26-5CB27A97BE4D

P304

Q51762261-CB511E42-B206-4119-9A80-A0F03B25DFEC

P31

Q51762261-47129A6D-CDB9-45E0-B2D4-9EA4AB486491

P356

Q51762261-B4D0E07F-8F2E-4EBB-918A-B26C0E9AEB18

P433

Q51762261-28A3423B-1D8C-42E0-800D-7644C650260E

P478

Q51762261-BFBE2640-43D0-4A23-BC82-0F354949D0B5

P50

Q51762261-01A20C12-FBCD-448C-A14E-DDA5955C4900

Q51762261-B0E5C2F3-F21E-4493-92C8-D530525EA0FE

P577

Q51762261-C92E55D5-5113-463E-93D0-B605CFA728D1

P698

Q51762261-E91EDC7D-06D9-4F62-B3C5-16D44E92281E

P356

ARCHNEUR.64.3.354

P1433

P1476

Association of low plasma Abet ...... airment and Alzheimer disease.

@en

P2093

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

John Lucas

http://www.w3.org/2001/XMLSchema#string

Julia E Crook

http://www.w3.org/2001/XMLSchema#string

Linda H Younkin

http://www.w3.org/2001/XMLSchema#string

Neill R Graff-Radford

http://www.w3.org/2001/XMLSchema#string

Robert J Ivnik

http://www.w3.org/2001/XMLSchema#string

Ronald C Petersen

http://www.w3.org/2001/XMLSchema#string

Steven G Younkin

http://www.w3.org/2001/XMLSchema#string

P304

354-362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUR.64.3.354

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

David S Knopman

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17353377

http://www.w3.org/2001/XMLSchema#string